HealthProtocols
← All sources

N=1 Reports on rapamycin.news

N=1 data from 4 participant(s). Steve_Combi (age 65–75): +10–17 ms (+24–43%); anon56293223: −10 bpm RHR / HRV into 120s ms; Tam: −37% HRV

N=1 Self-Experiment Data

Steve_Combi (age 65–75)

  • Protocol: Transcutaneous vagus nerve stimulation (tVNS) 3–4×/week
  • Before: HRV 40–47 ms
  • After: HRV 57+ ms
  • Change: +10–17 ms (+24–43%)
  • Duration: 3+ yrs
  • Device: Morning HRV app

anon56293223

  • Protocol: Stopped all polypharmacy (incl. suspected minoxidil) over Christmas 2024
  • Before: Elevated RHR / low HRV
  • After: RHR −10 bpm; HRV → 120s ms
  • Change: −10 bpm RHR / HRV into 120s ms
  • Duration: ~3 mo
  • Device: Oura Ring

Tam

  • Protocol: Rapamycin first week (dose unspecified)
  • Before: 60-day Athlytic average
  • After: Recovery 30% → 18%; HRV −37% from 60-day avg
  • Change: −37% HRV
  • Duration: First week
  • Device: Apple Watch / Athlytic

Neo (age 46)

  • Protocol: Zone 2 + resistance training + daily mindfulness + Pulsetto VNS (near-daily) + massage chair 2×/wk
  • Before: HRV 30s–40s ms
  • After: HRV high 50s–low 60s ms
  • Change: +20–30 ms over months
  • Duration: Several mo
  • Device: WHOOP 4.0 + Oura Ring (dual)

Outcomes

  • Heart Rate Variability
    40
    ms (RMSSD)
  • Heart Rate Variability
    57
    ms (RMSSD)
  • Heart Rate Variability
    13.5
    ms (RMSSD)
  • Heart Rate Variability
    43
    ms (RMSSD)
  • Resting Heart Rate
    10
    bpm (Beats Per Minute)
  • Heart Rate Variability
    37
    ms (RMSSD)
  • Heart Rate Variability
    30
    ms (RMSSD)
  • Heart Rate Variability
    25
    ms (RMSSD)
View original paper →